Cargando…

Forced-air prewarming prevents hypothermia during living donor liver transplantation: a randomized controlled trial

Despite various intraoperative thermal strategies, core heat loss is considerable during liver transplantation and hypothermia is common. We tested whether forced-air prewarming prevents hypothermia during liver transplantation. Adult patients undergoing living donor liver transplantation were rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Eun Jung, Han, Sangbin, Lee, Sooyeon, Choi, Eun Ah, Ko, Justin S., Gwak, Mi Sook, Kim, Gaab Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079654/
https://www.ncbi.nlm.nih.gov/pubmed/37024533
http://dx.doi.org/10.1038/s41598-022-23930-2
_version_ 1785020756102479872
author Oh, Eun Jung
Han, Sangbin
Lee, Sooyeon
Choi, Eun Ah
Ko, Justin S.
Gwak, Mi Sook
Kim, Gaab Soo
author_facet Oh, Eun Jung
Han, Sangbin
Lee, Sooyeon
Choi, Eun Ah
Ko, Justin S.
Gwak, Mi Sook
Kim, Gaab Soo
author_sort Oh, Eun Jung
collection PubMed
description Despite various intraoperative thermal strategies, core heat loss is considerable during liver transplantation and hypothermia is common. We tested whether forced-air prewarming prevents hypothermia during liver transplantation. Adult patients undergoing living donor liver transplantation were randomly assigned to non-prewarming group (n = 20) or prewarming group (n = 20). Patients in prewarming group underwent 30-min forced-air warming before anesthetic induction. During surgery, core temperature was measured in the pulmonary artery. The primary outcome was intraoperative hypothermia (< 36.0 °C). The secondary outcomes included plasma lactate concentration. Intraoperative hypothermia risk was significantly lower in prewarming group than in non-prewarming group (60.0% vs. 95.0%, P = 0.020). The difference in hypothermia incidence between groups was greater in the post-induction phase (20.0% vs. 85.0%, P < 0.001) than in the anhepatic or post-reperfusion phase, suggesting that prewarming mainly acts on preventing post-induction core-to-peripheral heat redistribution. Hypothermia duration was significantly shorter in prewarming group (60 [0–221] min vs. 383 [108–426] min, P = 0.001). Lactate concentration decreased during 3 h after graft reperfusion in prewarming group, whereas it continuously increased in non-prewarming group (− 0.19 [− 0.48 to 0.13] mmol/L vs. 1.17 [3.31–0.77] mmol/L, P = 0.034). In conclusion, forced-air prewarming decreases the incidence and duration of intraoperative hypothermia with potential clinical benefit while mainly acting by preventing the core-to-peripheral heat redistribution. Clinical trial registration: Registered at the Clinical Research Information Service (https://cris.nih.go.kr, [KCT0003230]) on 01/10/2018.
format Online
Article
Text
id pubmed-10079654
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100796542023-04-08 Forced-air prewarming prevents hypothermia during living donor liver transplantation: a randomized controlled trial Oh, Eun Jung Han, Sangbin Lee, Sooyeon Choi, Eun Ah Ko, Justin S. Gwak, Mi Sook Kim, Gaab Soo Sci Rep Article Despite various intraoperative thermal strategies, core heat loss is considerable during liver transplantation and hypothermia is common. We tested whether forced-air prewarming prevents hypothermia during liver transplantation. Adult patients undergoing living donor liver transplantation were randomly assigned to non-prewarming group (n = 20) or prewarming group (n = 20). Patients in prewarming group underwent 30-min forced-air warming before anesthetic induction. During surgery, core temperature was measured in the pulmonary artery. The primary outcome was intraoperative hypothermia (< 36.0 °C). The secondary outcomes included plasma lactate concentration. Intraoperative hypothermia risk was significantly lower in prewarming group than in non-prewarming group (60.0% vs. 95.0%, P = 0.020). The difference in hypothermia incidence between groups was greater in the post-induction phase (20.0% vs. 85.0%, P < 0.001) than in the anhepatic or post-reperfusion phase, suggesting that prewarming mainly acts on preventing post-induction core-to-peripheral heat redistribution. Hypothermia duration was significantly shorter in prewarming group (60 [0–221] min vs. 383 [108–426] min, P = 0.001). Lactate concentration decreased during 3 h after graft reperfusion in prewarming group, whereas it continuously increased in non-prewarming group (− 0.19 [− 0.48 to 0.13] mmol/L vs. 1.17 [3.31–0.77] mmol/L, P = 0.034). In conclusion, forced-air prewarming decreases the incidence and duration of intraoperative hypothermia with potential clinical benefit while mainly acting by preventing the core-to-peripheral heat redistribution. Clinical trial registration: Registered at the Clinical Research Information Service (https://cris.nih.go.kr, [KCT0003230]) on 01/10/2018. Nature Publishing Group UK 2023-04-06 /pmc/articles/PMC10079654/ /pubmed/37024533 http://dx.doi.org/10.1038/s41598-022-23930-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Oh, Eun Jung
Han, Sangbin
Lee, Sooyeon
Choi, Eun Ah
Ko, Justin S.
Gwak, Mi Sook
Kim, Gaab Soo
Forced-air prewarming prevents hypothermia during living donor liver transplantation: a randomized controlled trial
title Forced-air prewarming prevents hypothermia during living donor liver transplantation: a randomized controlled trial
title_full Forced-air prewarming prevents hypothermia during living donor liver transplantation: a randomized controlled trial
title_fullStr Forced-air prewarming prevents hypothermia during living donor liver transplantation: a randomized controlled trial
title_full_unstemmed Forced-air prewarming prevents hypothermia during living donor liver transplantation: a randomized controlled trial
title_short Forced-air prewarming prevents hypothermia during living donor liver transplantation: a randomized controlled trial
title_sort forced-air prewarming prevents hypothermia during living donor liver transplantation: a randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079654/
https://www.ncbi.nlm.nih.gov/pubmed/37024533
http://dx.doi.org/10.1038/s41598-022-23930-2
work_keys_str_mv AT oheunjung forcedairprewarmingpreventshypothermiaduringlivingdonorlivertransplantationarandomizedcontrolledtrial
AT hansangbin forcedairprewarmingpreventshypothermiaduringlivingdonorlivertransplantationarandomizedcontrolledtrial
AT leesooyeon forcedairprewarmingpreventshypothermiaduringlivingdonorlivertransplantationarandomizedcontrolledtrial
AT choieunah forcedairprewarmingpreventshypothermiaduringlivingdonorlivertransplantationarandomizedcontrolledtrial
AT kojustins forcedairprewarmingpreventshypothermiaduringlivingdonorlivertransplantationarandomizedcontrolledtrial
AT gwakmisook forcedairprewarmingpreventshypothermiaduringlivingdonorlivertransplantationarandomizedcontrolledtrial
AT kimgaabsoo forcedairprewarmingpreventshypothermiaduringlivingdonorlivertransplantationarandomizedcontrolledtrial